Press Releases

Curebase Releases Diagnostic Offering that Delivers First All-Inclusive Package of Software and Services Needed to Fully Execute Diagnostic Studies

Start-up trials achieved in eight to 12 weeks, a fraction of typical timeframe

InsightRX Provides Máxima Medical Center with Precision Dosing Guidance

Large teaching hospital in the Netherlands relies on precision dosing platform for point-of-care decision support and immunology research

CluePoints Appoints Andy Cooper as New Chief Executive Officer

CluePoints Appoints Andy Cooper as New Chief Executive Officer New CEO brings a combination of experience and drive as CluePoints rapidly scales its RBQM and Data Quality Oversight offerings

MultiCare Partners with IllumiCare to Offer Clinical Trials at Point-of-Care with Trials App

MultiCare Health System is the first to use the Illumicare Trials App in a clinical setting, streamlining clinical trial recruitment and increasing awareness among providers, patients and clinical research teams.

Digital Therapeutics Alliance and Curebase release publication setting the stage for a fit-for-purpose evidence standard for digital therapeutics (DTx)

Digital Therapeutics Alliance and Curebase release publication setting the stage for a fit-for-purpose evidence standard for digital therapeutics (DTx)

Tesis Biosciences Announces Proposed Study of Veterans and Civilians with Mild Traumatic Brain Injury

Tesis Biosciences Announces Proposed Study of Veterans and Civilians with Mild Traumatic Brain Injury - Company in preparation for formal FDA approval submission

International Organization for Standardization Publishes Revisions to ISO 15189

International Organization for Standardization publishes revisions to ISO 15189.

Emmes Launches Cell and Gene Therapy Center

PHASTAR Joins Oncology Development Programme (ODP2) to Accelerate Development of Novel Cancer Innovations

PHASTAR Joins Oncology Development Programme (ODP2) to Accelerate Development of Novel Cancer Innovations London, UK and Durham, NC – 08 December, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO), has joined Lean Life Science’s Oncology Development Programme (ODP2). The targeted programme aims to identify and accelerate novel oncology innovations into commercially-attractive assets by offering support to academics and early-stage companies.

Verana Health and the American Academy of Ophthalmology Launch the Verana Research Network, an IRIS Registry Initiative

Partnership seeks to increase clinical trials access, accelerate recruitment, and advance ophthalmic research

PHASTAR Launches Pro-Bono Scheme for Charities

PHASTAR, a global specialist biometrics contract research organization (CRO), has announced the launch of a pro-bono scheme to give charities access to its volunteer statisticians, data scientists, data managers and programmers at no cost.

Recipharm announces extension of commercial manufacturing to support RedHill Biopharma’s Talicia® to 2026

Global contract development and manufacturing organization (CDMO) Recipharm, today announced an extension of the ongoing commercial manufacturing of RedHill Biopharma’s (Nasdaq: RDHL) drug, Talicia® for the treatment of H. pylori infection, to 2026.

New startup Graegis Pharmaceuticals to prevent skin and mucosa side effects of radiotherapy

Graegis Pharmaceuticals has announced its plan to start proof-of-concept clinical trials in 2023 in the prevention of radiation-induced dermatitis and mucositis.

IDDI (International Drug Development Institute) Appoints Linda Danielson as its new Chief Executive Officer.

IDDI appoints new CEO, to strengthen the organization's position to support and serve US and EU clients.

Lonza’s API Mid-Scale Manufacturing Facility Expansion in Nansha Enters Commercial Operation

MIB Agents Awards $100,000 Grant for Pediatric Osteosarcoma Research at MD Anderson

MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, has awarded a $100,000 research grant to Andy Livingston, M.D., a clinician and researcher in Sarcoma Medical Oncology and in Pediatric Oncology at The University of Texas MD Anderson Cancer Center. Ann Graham, Founder and Executive Director of MIB Agents, and Christina Ip-Toma, MIB Agents’ Director of Scientific Programs, presented the award to Dr. Livingston on Dec. 1 in Houston.

The Mobile Health/Central Lab Interface, an opportunity for DCT efficiency

The Mobile Health/Central Lab Interface, an opportunity for DCT efficiency How streamlining relations between central labs and mobile health providers can get the most from hybrid and decentralised clinical trials

Emplicure AB and Quotient Sciences Announce an Integrated Manufacturing and Clinical Testing Partnership for Emplicure’s First Clinical Pharmacokinetic Study for EMPLI03

Quotient Sciences, a global drug development and manufacturing accelerator, today announced a partnership with Emplicure, a Swedish pharmaceutical company focused on chronic pain and abuse-deterrent formulations.

Upgrading to FFP3 face masks in hospitals could save the NHS £360m a year and help slash patient waiting lists

The NHS could save up to £360M per year by using FFP3 face masks and the NHS already has a large stockpile of these masks so there is no current need to purchase more. Independent studies commissioned by PPE manufacturer Globus Group and carried out by York Economic Health Consortium and Vital Economics confirm that these masks may be better at preventing respiratory infection and resulting staff days off.

Scipio bioscience Announces a Single-Cell Grant Program for Four Researchers to Receive a Complete 3′ scRNA-seq Solution Valued up to US$30,000

Scipio bioscience has announced a grant program for researchers to receive a complete 3′ scRNA-seq solution valued at up to US$30,000.